BioNTech

Recent news

• Rating change
  A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $135 to $140
  Market Newswire · 2026/9/16
• Rating change
  BMO Capital Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $128
  Market Newswire · 2026/8/29
• BioNTech(BNTX.US) 10% Shareholder Sells US$6.48 Million in Common Stock
  Market Newswire · 2026/10/1
• BioNTech(BNTX.US) 10% Shareholder Sells US$6.84 Million in Common Stock
  Market Newswire · 2026/9/25
• Rating change
  Citi Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $125
  Market Newswire · 2026/8/31
• Rating change
  CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $142
  Market Newswire · 2026/8/20
• Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $115
  Market Newswire · 2026/9/28
• Rating change
  BMO Capital Downgrades BioNTech(BNTX.US) to Hold Rating, Cuts Target Price to $105
  Market Newswire · 2026/9/8
• Rating change
  Evercore Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $130
  Market Newswire · 2026/8/6
• Rating change
  Goldman Sachs Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $127
  Market Newswire · 2026/9/4
• BioNTech(BNTX.US) 10% Shareholder Sells US$6.01 Million in Common Stock
  Market Newswire · 2026/9/29
• Rating change
  BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $122
  Market Newswire · 2026/9/15
• Rating change
  Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $140
  Market Newswire · 2026/8/26
• Rating change
  Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $115
  Market Newswire · 2026/8/5
• Rating change
  Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $138
  Market Newswire · 2026/8/20
• Rating change
  UBS Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $135
  Market Newswire · 2026/9/17
• Rating change
  CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Cuts Target Price to $136
  Market Newswire · 2026/8/31
• Rating change
  CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $136
  Market Newswire · 2026/9/23
• Rating change
  J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating
  Market Newswire · 2026/8/20
• Wells Fargo Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $140
  Market Newswire · 2026/9/25

Headlines are aggregated automatically and are not independently verified or edited by our team.